← Back to headlines
Jim Cramer Criticizes ImmunityBio Stock as 'Magical Thinking Era'
Financial commentator Jim Cramer has expressed skepticism about ImmunityBio, stating that its stock is indicative of a 'magical thinking era' in the market.
21 Mar, 16:31 — 21 Mar, 16:31
Sources
Showing 1 of 1 sources

